Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:00
Welcome to Public Health
0:02
on Call, a podcast from
0:04
the Johns Hopkins Bloomberg School
0:06
of Public Health, where
0:09
we bring evidence, experience,
0:11
and perspective to make sense
0:13
of today's leading health challenges.
0:15
If you have questions or
0:18
ideas for us, please send
0:20
an email to Public Health
0:22
Question at JHU.EDU. That's Public
0:25
Health Question at JHU. EDU.
0:27
for future podcast episodes. Hi
0:29
listeners, it's Lindsay Smith-Rogers. Today,
0:32
a look at preventing ovarian
0:34
cancer, which can be difficult
0:36
to diagnose and treat. Stephanie
0:38
Desmond talks to Dr. Rebecca
0:40
Stone, the director of gynecologic
0:42
oncology at Johns Hopkins, about
0:44
changes in how we understand
0:46
ovarian cancer, that much of
0:49
what is called ovarian cancer
0:51
may actually start in the
0:53
fallopian tubes. and about an
0:55
under-use surgery that preserves ovaries
0:57
and may save lives. Let's
0:59
listen. Rebecca Stone, thanks so
1:01
much for joining me. Thank you so
1:03
much for having me. It's a real
1:05
pleasure. So today I want to
1:07
talk about something with a difficult
1:10
name to say, but it actually
1:12
could save a lot of people's
1:14
lives. So we're talking about salpingectomy,
1:16
which is the removal of the
1:19
fallopian tubes, and I understand that
1:21
this could really... a game changer
1:23
in ovarian cancer. Could you talk
1:25
to me a little bit about,
1:27
maybe about, let's start with ovarian
1:29
cancer, right? It's hard to screen
1:31
war and it's deadly, and this
1:33
can reduce the risk. Tell me,
1:35
please. I think sometimes when I talk
1:38
to people about this, the first thing,
1:40
they're thinking is, well, okay,
1:42
you're talking to me about ovarian
1:44
cancer, and then you're talking about
1:46
a structure that's not the
1:48
ovary. You're talking about the
1:50
fallopian tube, and so How do you
1:53
make sense of those two things? And
1:55
this is the fact that we're
1:57
talking about the fallopian tube is
1:59
real. to a
2:01
relatively recent scientific discovery that
2:03
a large number of ovarian
2:05
cancers or types of cancer
2:07
that we have historically called
2:09
ovarian cancer actually originate either
2:11
directly or indirectly from the
2:13
fallopian tube and you know
2:15
many people have not thought
2:17
about gynecologic anatomy or function
2:20
ever or maybe it was
2:22
many many years ago but
2:24
you may remember the fallopian
2:26
tube is this small thin
2:28
structure that arises from the
2:30
top of the uterus or
2:32
the womb and sits immediately
2:34
adjacent to the ovary and
2:36
so when the ovary produces
2:38
an egg the fallopian tube
2:40
grabs that egg and the
2:42
egg goes into the tube
2:44
and then maybe if it
2:46
meets a sperm there, there's
2:48
fertilization event and then pregnancy
2:50
can happen. And so you
2:52
can imagine that if when
2:54
a cancer starts in either
2:56
the fallopian tube or ovary,
2:58
it sometimes might be hard
3:00
to discern, you know, which
3:02
was truly the primary site
3:04
of the cancer because they're
3:06
so, you know, they're, we
3:09
always say they're frenemies or
3:11
they live so, you know,
3:13
they live so, you know,
3:15
closely next to each other.
3:17
And so, you know, in
3:19
medicine historically, there has been
3:21
a group of cancers that
3:23
we have called ovarian cancer.
3:25
And I tell people, maybe
3:27
it helps to think about
3:29
the ovary sort of like
3:31
a grape. And you might
3:33
think a grape sort of
3:35
has three layers. It has
3:37
the skin of the grape,
3:39
the fruit of the grape,
3:41
and then the seed, like
3:43
the germanal center. and traditionally
3:45
ovarian cancers have been attributed
3:47
to one of those three
3:49
layers. With the most, the
3:51
highest prevalence or most common
3:53
types of rising... from what
3:55
people thought to be from
3:57
the skin of the grape.
4:00
And that maybe is like
4:02
90% of ovarian cancers historically
4:04
were attributed to the skin
4:06
of the grape and only
4:08
about 10% to the fruit
4:10
or the sea, the Germanal
4:12
center. But as you know,
4:14
people have really studied ovarian
4:16
cancer and looked at, you
4:18
know, what do the cells
4:20
look like under the microscope?
4:22
and we've started to learn
4:24
more about, particularly about people
4:26
and families that have this
4:28
hereditary risk of ovarian cancer,
4:30
we really have come to
4:32
accept that many of the
4:34
cancers that we thought arose
4:36
from the skin of the
4:38
grape, the surface of the
4:40
ovary, actually appear to come
4:42
from the end of the
4:44
fallopian tube that sits right
4:46
next to the ovary. And
4:48
so if you Google ovarian
4:51
cancer... you will often see
4:53
pictures of and read about
4:55
a type called high-grade cirrus
4:57
cancer, which is the most
4:59
common and deadly type of
5:01
cancer that people had traditionally
5:03
attributed to the ovary. In
5:05
most cases, it comes from
5:07
that end of the fallopian
5:09
tube. So, that then brings
5:11
us to, you know, why
5:13
are people talking about the
5:15
fallopian tube so much because...
5:17
Now that we really understand
5:19
that most types of ovarian
5:21
cancer, most cases of ovarian
5:23
cancer are starting in the
5:25
tube instead of the ovary,
5:27
explains why in medicine we've
5:29
never been able to develop
5:31
a screening test because, you
5:33
know, many of our screening
5:35
tests have relied on imaging,
5:37
like ultrasound, but there really
5:40
is no imaging in medicine
5:42
that can routinely see a
5:44
fallopian tube. Which is shocking
5:46
to most people. I mean,
5:48
it was sort of shocking
5:50
to me, and I'm a
5:52
doctor, right? And I've, you
5:54
know, this has been an
5:56
area of interest of mine
5:58
for many, many years. And
6:00
when you really sit down
6:02
and think about it, the
6:04
fact that we actually don't
6:07
have imaging for a critical
6:09
structure in the body, like the
6:11
fallopian tube, is surprising.
6:13
So what do we do about that?
6:15
I think this is the question of
6:18
the day, right, which is if we
6:20
can't screen for ovarian cancer, right,
6:22
with imaging or blood tests,
6:25
and it's a cancer that
6:27
we don't have... a reliable
6:29
way to eradicate, meaning we
6:31
can't cure it in many cases,
6:33
it's very dangerous, then is
6:36
there something that we could do
6:38
to prevent it? You know, when you
6:40
think about the option for prevention
6:42
being ovarian removal, well that's
6:45
not so great because the
6:47
ovaries are an important endocrine
6:49
organ, probably well past menopause,
6:52
and this is a real
6:54
active area of research. So,
6:56
you know, the idea that we
6:58
could prevent a cancer by removing
7:01
the ovaries is not so exciting,
7:03
but knowing that to prevent
7:05
ovarian cancer or many
7:07
cases of ovarian cancer
7:09
in a way that doesn't involve
7:11
removing the ovaries, but
7:13
rather the fallopian tube, which
7:16
in medicine doesn't have any
7:18
known form or function once
7:20
a person has completed
7:22
family planning. Well, that's actually
7:25
a more interesting idea
7:27
because the fallopian tube
7:29
doesn't make any hormones like the
7:31
ovary and its job in life
7:34
is to help with pregnancy. And
7:36
so if either someone doesn't want
7:39
pregnancy or they're never
7:41
planning on pregnancy, then
7:43
removal of the fallopian tube can
7:45
be a very good option
7:47
for prevention of... this
7:49
type of cancer that has a
7:51
misnomer now, right? We've called it
7:54
ovarian cancer, when in fact it
7:56
is largely fallopian tube cancer. And,
7:58
you know, the next most... common people
8:00
ask, question people ask is like,
8:02
well, how successful is this? Right?
8:04
How good is this as a
8:07
preventive strategy? And so I tell
8:09
people, well, when you think about
8:11
the most common and deadly type
8:13
of ovarian cancer, this type called
8:15
high grade cirrus, fallopian tube removal
8:17
right now, based upon existing data,
8:20
it's projected to prevent about 80
8:22
% of those cases, which is
8:24
just like amazing. And when you
8:26
think about ovarian cancer in general,
8:28
memory told you, not all not
8:31
all cancers come from the fallopian
8:33
tube. Some still primarily come from
8:35
the ovary. If you were to
8:37
look at what fraction of ovarian
8:39
cancer in general does fallopian tube
8:41
removal prevent, it's probably on the
8:44
order of maybe 50 to 65%.
8:46
So still the majority, which is,
8:48
which is very impressive. And it's
8:50
a procedure that is generally speaking,
8:52
you know, can be done as
8:55
standalone outpatient surgery. It could be
8:57
done in lieu of like a
8:59
tubal ligation, right, which is probably
9:01
the most common time in a
9:03
person's life when they might be
9:05
considering a self -inject me, fallopian tube
9:08
removal. You're thinking about getting your
9:10
tubes tied or it can be
9:12
a procedure that is done at
9:14
the same time as another procedure.
9:16
And that's often called opportunistic, meaning
9:19
taking the opportunity to offer somebody
9:21
preventative surgery. Or ovarian cancer. So
9:23
it could be done at hysterectomy
9:25
or people are starting to think
9:27
about what are the other scenarios
9:29
when it could be done. And
9:32
lots of people have surgery on
9:34
their abdomen in their, we say
9:36
post reproductive years. So they have
9:38
hernia, a pair, is it maybe
9:40
their gallbladder out or more other
9:43
procedures when, if they knew this
9:45
was an option, they might know
9:47
they could ask their surgeon about,
9:49
about the chance. So this is
9:51
not commonly known though. Tell me
9:53
about why we don't know much
9:56
about this. And also you make
9:58
it sound super easy. And I
10:00
imagine. it's not as easy as you've just made it
10:02
sound. It's not so hard but you
10:04
know I think there are lots of
10:07
considerations and we could talk briefly about
10:09
those. I think the first question is
10:11
why don't people know about this and
10:13
and a lot of people you know
10:15
they're kind of what's the word you know
10:18
shocked and surprised that they don't know
10:20
about this because it seems like such
10:22
an important discovery and it is you
10:25
know in health. Really, this has
10:27
been something that has been
10:29
embraced in the field of
10:31
OBGYN, particularly when thinking about
10:33
taking the opportunity to reduce
10:35
risk at the time of
10:37
like a hysterectomy. But
10:39
beyond that, people have not
10:42
really committed to creating, you
10:44
know, knowledge mobilization around this for
10:46
whatever reason. I mean, primarily, you
10:48
know, we're not good at this
10:51
in medicine, right? We're not good
10:53
at... conveying complex things
10:55
or telling people about
10:57
new scientific discovery. It's
11:00
just something that medicine
11:02
has not done well,
11:04
unfortunately. And there are some
11:07
barriers to implementing this in
11:09
the field of OBGYN and
11:11
then into surgical practice more
11:13
broadly. You know, in the
11:15
field of OBGYN, I had mentioned
11:17
one of the most common
11:20
times that a person might
11:22
consider a salpingectomy would be
11:24
at the time of permanent
11:26
contraception, right? So tubalagation. There
11:28
are some structural barriers to
11:30
being able to have access to
11:32
or to choose a salpingectomy instead
11:34
of a tubalagation. One of them,
11:37
you know, being like, for instance,
11:39
in our state and in a
11:41
number of other states, there's outdated
11:43
health policy. And there's also
11:45
not a insurance infrastructure
11:48
that is fail safe
11:50
to guarantee coverage. And that's
11:52
something that you know we are
11:54
really working on a lot of
11:57
advocacy to address. And then in
11:59
terms of translating this into surgical
12:01
practice more broadly, that has a
12:03
lot of important considerations. You know,
12:06
one being that it shouldn't be
12:08
something that a woman, we think,
12:10
or a person hears about for
12:13
the first time, you know, when
12:15
they are needing to have their
12:17
gallbladder out, right? This is really
12:19
something that someone should hear about,
12:22
you know, during their engagement in
12:24
their health throughout their lifetime. really
12:26
hasn't happened. Right now I think
12:29
people are thinking, okay, well, you
12:31
know, if a person needs X,
12:33
Y, Z procedure, you know, they
12:36
could, like they're coming into the
12:38
doctor for it or, you know,
12:40
God forbid they're in their emergency
12:42
or whatever, you know, they could
12:45
receive counseling about this at that
12:47
time, but it's not the most
12:49
ideal time for something like that
12:52
to happen. And it's better if
12:54
people have heard about this throughout
12:56
their health journey and they're prepared.
12:59
consider having a tubalagation for instance
13:01
and I think I might prefer
13:03
a cell conjectony instead or if
13:06
I need a hysterectomy I know
13:08
to talk to my doctor about
13:10
this or I know that if
13:12
I end up in my post-reproductive
13:15
years needing surgery for something that
13:17
I would like to also have
13:19
this. So it's sort of something
13:22
that the patient plans and they're
13:24
empowered to plan and choose. And
13:26
the other reason is that there
13:29
haven't been a lot of education
13:31
materials created about this in OBGYN,
13:33
let alone materials that could be
13:35
used by doctors that are non-obGYN
13:38
doctors who are not familiar with
13:40
counseling people about reproductive anatomy and
13:42
physiology and alternatives even, right? I
13:45
think that the alternatives part of
13:47
it is also really important because
13:49
there are options besides surgery to
13:52
decrease the risk of ovarian cancer.
13:54
For instance, we've known for a
13:56
long time that when people take
13:58
birth control pills, particularly for a
14:01
prolonged period of time or for
14:03
at least five years in their
14:05
life, that that decreases the risk
14:08
of ovarian cancer as well, probably
14:10
upwards of 40 to 50%. So
14:12
if somebody were to have, for
14:15
example, an ovarian cancer gene, this
14:17
could really be a solution that
14:19
is less damaging than, say removing
14:22
the ovaries. Yeah, so I think
14:24
what you're asking is if you
14:26
have had genetic testing due to
14:28
typically a family history, right, where
14:31
there are a number of people
14:33
who have been affected by breast
14:35
cancer, ovarian cancer, sometimes pancreatic cancer,
14:38
or colon cancer, what about the
14:40
option of removing the fallopian tube
14:42
instead of the ovary, for instance?
14:45
And I think that's a really
14:47
good question. That's something that that
14:49
is being studied right now. And
14:51
as you pointed out, the standard
14:54
of care for people who have
14:56
a high risk of developing ovarian
14:58
cancer in their lifetime due to
15:01
a gene mutation, for instance, and
15:03
these people, you know, have upwards
15:05
of a 40% chance of developing
15:08
ovarian cancer by age 80, the
15:10
standard of care has been removal
15:12
of the ovaries. And really, the
15:14
fallopian tube was just along for
15:17
the ride, right, when this started
15:19
in the early 2000s. you know
15:21
people would remove the ovary, the
15:24
fallopian tube would be removed as
15:26
well because there's no point in
15:28
keeping the fallopian tube if you're
15:31
taking the ovaries out and they
15:33
share a blood supply and people
15:35
would look at the ovary and
15:37
they couldn't never find any evidence
15:40
that ovarian cancer started there until
15:42
people started looking at the fallopian
15:44
tube and so really from this
15:47
emerged the idea of you know
15:49
maybe we were going about it
15:51
all wrong and We actually need
15:54
to focus on fallopian tube removal
15:56
instead of ovarian removal. But we
15:58
don't know for sure yet. And
16:01
we know that risk reducing surgery
16:03
as it has been done since
16:05
early 2000. which means removal of
16:07
the tube and the ovary on
16:10
both sides, is highly effective at
16:12
preventing ovarian cancer. You know, anywhere
16:14
between near 100% to somewhat less
16:17
than that, depending upon what's found
16:19
in the fallopian tube at the
16:21
time of risk-producing surgery. But we
16:24
don't know how effective it is
16:26
to just have the fallopian tube
16:28
out and to keep the ovary.
16:30
or to do what's called a
16:33
stage surgery where you have the
16:35
fallopian tubes out as soon as
16:37
you've completed family planning and you
16:40
wait to have the ovaries out
16:42
until you're closer to the natural
16:44
age of metapoles. What is your
16:47
aim here? So my aim, I'm
16:49
a person who takes care of
16:51
a lot of patients and families
16:53
who are affected by this disease
16:56
and who suffer from this disease
16:58
and die from it. And it
17:00
has really been one of the
17:03
most important areas of clinical medicine
17:05
for me throughout my life. And
17:07
I've dedicated countless hours and love
17:10
and devotion to it. And sitting
17:12
honestly with my patients, many patients
17:14
who are suffering from this, their
17:17
life, I have promised them that
17:19
I would continue to work on.
17:21
developing opportunities to prevent the disease,
17:23
truly like in their honor. And
17:26
that is literally what motivates me.
17:28
And you know, it's gotten to
17:30
the point, Stephanie, where I honestly
17:33
couldn't sleep anymore, knowing that, you
17:35
know, so many people in the
17:37
United States have an opportunity to
17:40
know about this and to choose
17:42
it, right? Because people actually choose
17:44
to litigation more than any. other
17:46
method of family planning in the
17:49
United States. Lots of people have
17:51
hysterectomies and other surgeries where, you
17:53
know, if they knew about this,
17:56
they could have the opportunity to...
17:58
bent the disease,
18:01
that people didn't know about this,
18:03
that this was so siloed in the
18:05
field of OBGYN, I
18:07
couldn't sleep anymore about it. And so I just
18:09
decided I was just gonna work on it and
18:11
for the rest of my life until I got
18:14
as far as I could. So you're
18:16
out here spreading the word. Rebecca Stone, thank
18:18
you so much for your time. Of
18:20
course, thank you so much for having
18:23
me and for really caring about
18:25
this. MUSIC Public
18:29
Health On Call is a
18:31
podcast from the Johns
18:33
Hopkins Bloomberg School of Public
18:35
Health, produced by Joshua
18:37
Sharfstein, Lindsay Smith Rogers, Stephanie
18:39
Desmond, and Grace Fernandez -Sissiri.
18:41
Audio production by J .B.
18:44
Arbogast, Michael Bonfills, Spencer
18:46
Greer, Matthew Martin, and Phillip
18:48
Porter, with support from
18:50
Chip Hickey. Distribution by Nick
18:52
Moran. Production Coordination by
18:54
Catherine Ricardo. Social Media, run
18:56
by Grace Fernandez -Sissiri. Analytics
18:59
by Alisa Rosen.
19:01
If you have questions
19:03
or ideas for
19:05
us, please send an
19:07
email to publichealthquestionatjhu .edu.
19:09
That's publichealthquestionatjhu .edu for
19:11
future podcast episodes. Thank
19:14
you for listening. MUSIC
19:23
.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More